Pressure-regulating vial adaptors

Information

  • Patent Grant
  • 10987277
  • Patent Number
    10,987,277
  • Date Filed
    Tuesday, December 18, 2018
    5 years ago
  • Date Issued
    Tuesday, April 27, 2021
    3 years ago
Abstract
According to some embodiments of the present disclosure, an adaptor configured to couple with a sealed vial can include a connector interface. The adaptor can include one or more access channels (e.g., passages). In some cases the one or more access channels are in fluid communication with the connector interface. The adaptor can include a piercing member. The piercing member can include a regulator channel. The adaptor can include a regulator assembly. The regulator assembly can include a first regulator inlet. In some cases, the regulator includes a second regulator inlet. One or more of the first and second regulator inlets can include a filter configured to filter fluid passing into and/or out of the respective regulator inlets. One or more valves can be positioned between the first and/or second regulator inlets and the piercing member.
Description
SUMMARY

According to some embodiments of the present disclosure, an adaptor configured to couple with a sealed vial can include a connector interface. The adaptor can include one or more access channels (e.g., passages). In some cases the one or more access channels are in fluid communication with the connector interface. The adaptor can include a piercing member. The piercing member can include a regulator channel. The adaptor can include a regulator assembly. The regulator assembly can include a first regulator inlet. In some cases, the regulator includes a second regulator inlet. One or more of the first and second regulator inlets can include a filter configured to filter fluid passing into and/or out of the respective regulator inlets. One or more valves can be positioned between the first and/or second regulator inlets and the piercing member.


According to some variants, an adaptor configured to couple with a sealed vial can include a connector interface. In some embodiments, the adaptor includes an access channel. The access channel can be in fluid communication with the connector interface. In some cases, the adaptor includes a regulator assembly. The regulator assembly can include a first regulator inlet. The first regulator inlet can be in fluid communication with an ambient environment surrounding the adaptor. In some embodiments, the regulator assembly includes a first regulator lumen. In some cases, the regulator assembly includes a second regulator inlet. The second regulator inlet can be in fluid communication with the ambient environment. In some cases, the regulator assembly includes a second regulator lumen. In some embodiments, the regulator assembly includes a first filter. The first filter can be capable of fluid communication with the first regulator lumen. In some embodiments, the first filter is configured to filter fluid passing into the first regulator lumen. The regulator assembly can include a second filter. The second filter can be in fluid communication with the second regulator lumen. In some embodiments, the second filter is configured to filter fluid passing from the second regulator lumen and into the ambient environment. In some embodiments, the regulator assembly includes a regulator valve. The regulator valve can be in fluid communication with the first regulator lumen. In some embodiments, the regulator valve is configured to permit passage of fluid from the ambient environment into the first regulator lumen. In some cases, the regulator valve is configured to prevent passage of fluid from within the vial to the first filter. The adaptor can include a piercing member. The piercing member can include a proximal end and a distal end. In some embodiments, the distal end comprises a piercing tip. In some cases, the adaptor includes a regulator channel. The regulator channel can be positioned at least partially within the piercing member. In some embodiments, the regulator channel includes a first regulator channel opening in fluid communication with the first regulator lumen. In some embodiments, the adaptor can be used in conjunction with a sealed vial.


In some embodiments, the regulator valve comprises a valve stem and/or a flap portion. In some cases, the flap portion comprises a concave side and/or a convex side. In some embodiments, the first regulator lumen and the second regulator lumen are in fluid communication with each other. In some configurations, the regulator valve is positioned in a plug portion. In some cases, the plug portion can be inserted into the regulator lumen. In some embodiments, the plug portion is flexible. In some embodiments, the plug portion is retained within the regulator lumen (e.g., by a friction fit). In some cases, a cap portion limits the extent to which the plug portion is inserted into the regulator lumen. In some embodiments, the first filter is positioned in the plug portion. In some cases, the first filter is positioned within the first regulator lumen. In some embodiments, the second filter is positioned within the second regulator lumen. In some cases, the first and second filters are positioned along a common line. In some embodiments, the common line is generally perpendicular to the regulator channel. In some cases, the regulator valve is positioned along the common line.


According to some variants, a method of manufacturing a vial adaptor can include providing a connector interface. In some embodiments, the method includes providing an access channel. The access channel can be in fluid communication with the connector interface. The method can include providing a regulator assembly. The regulator assembly can include a first regulator inlet. The first regulator include can be in fluid communication with an ambient environment surrounding the adaptor. In some cases, the regulator assembly includes a second regulator inlet. The second regulator inlet can be in fluid communication with the ambient environment. The regulator assembly can include a first filter. The first filter can be configured to filter fluid passing into the vial adaptor. In some embodiments, the regulator assembly includes a second filter. The second filter can be configured to filter fluid passing from the vial adaptor into the ambient environment. In some cases, the regulator assembly includes a regulator valve. The regulator valve can be configured to permit passage of fluid from the ambient environment into the vial adaptor. In some embodiments, the regulator valve is configured to inhibit passage of fluid from within the vial to the first filter. The method can include providing a piercing member. The piercing member can include a proximal end and a distal end. In some cases, the distal end includes a piercing tip. In some embodiments, the method includes providing a regulator channel. The regulator channel can be positioned at least partially within the piercing member. In some embodiments, the regulator channel includes a first regulator channel opening. In some cases, the regulator channel is in fluid communication with the second filter and/or with the regulator valve. In some embodiments, the first and second regulator inlets are provided along a common line that is generally perpendicular to the regulator channel. In some cases, the regulator valve is providing along the common line. In some embodiments, the regulator valve is configured to prevent passage of fluid from within the vial to the first filter. In some cases, the regulator valve comprises a valve stem and/or a flap portion. In some embodiments, the flap portion has a concave side and/or a convex side


BACKGROUND
Field

Certain embodiments disclosed herein relate to adaptors for coupling with medicinal vials, and components thereof, and methods to contain vapors and/or to aid in regulating pressures within medicinal vials.


Description of Related Art

It is a common practice to store medicines or other medically related fluids in vials or other containers. In some instances, the medicines or fluids so stored are therapeutic if injected into the bloodstream, but harmful if inhaled or if contacted by exposed skin. Certain known systems for extracting potentially harmful medicines from vials suffer from various drawbacks.





BRIEF DESCRIPTION OF THE DRAWINGS

Various embodiments are depicted in the accompanying drawings for illustrative purposes, and should in no way be interpreted as limiting the scope of the embodiments. In addition, any features of different disclosed embodiments can be combined to form additional embodiments, which are part of this disclosure.



FIG. 1 schematically illustrates a system for removing compounds from and/or injecting compounds into a vial.



FIG. 2 schematically illustrates another system for removing compounds from and/or injecting compounds into a vial.



FIG. 2A schematically illustrates another system for removing compounds from and/or injecting compounds into a vial.



FIG. 2B schematically illustrates another system for removing compounds from and/or injecting compounds into a vial.



FIG. 3 is a top perspective view of a vial adaptor.



FIG. 4 is a front plan view of the vial adaptor of FIG. 3.



FIG. 5 is a right plan view of the vial adaptor of FIG. 3.



FIG. 6 is a left plan view of the vial adaptor of FIG. 3.



FIG. 7 is a front cross-sectional view of the vial adaptor of FIG. 3.



FIG. 8 is a close up front cross-section view of the regulator valve of FIG. 3.



FIG. 9 is a top right perspective cross-section view of the vial adaptor of FIG. 3.



FIG. 10 is a top left perspective cross-section view of the vial adaptor of FIG. 3.



FIG. 11 is a front cross-sectional view of another embodiment of a vial adaptor.





DETAILED DESCRIPTION OF CERTAIN EMBODIMENTS


FIG. 1 is a schematic illustration of a container 10, such as a medicinal vial, that can be coupled with an accessor 20 and a regulator 30. In certain arrangements, the regulator 30 allows the removal of some or all of the contents of the container 10 via the accessor 20 without a significant change of pressure within the container 10. In some embodiments, the regulator 30 can include one or more portions of any of the example regulators shown and/or described in International Patent Publication Number WO 2013/025946, titled PRESSURE-REGULATING VIAL ADAPTORS, filed Aug. 16, 2012, the entire contents of which are incorporated by reference and made part of this specification. Every individual structure, component, feature, or step that is illustrated or described in any embodiment in this specification can be used alone or in combination with any other structure, component, feature, or step that is illustrated or described in any other embodiment in this specification. No structure, component, feature, or step in this specification is indispensable or essential, but rather can be omitted in some embodiments.


In general, the container 10 is hermetically sealed to preserve the contents of the container 10 in a sterile environment. The container 10 can be evacuated or pressurized upon sealing. In some instances, the container 10 is partially or completely filled with a liquid, such as a drug or other medical fluid. In such instances, one or more gases can also be sealed in the container 10. In some instances, a solid or powdered substance, such as a lyophilized pharmaceutical, is disposed in the container 10.


The accessor 20 generally provides access to contents of the container 10 such that the contents may be removed or added to. In certain arrangements, the accessor 20 includes an opening between the interior and exterior of the container 10. The accessor 20 can further comprise a passageway between the interior and exterior of the container 10. In some configurations, the passageway of the accessor 20 can be selectively opened and closed. In some arrangements, the accessor 20 comprises a conduit extending through a surface of the container 10. The accessor 20 can be integrally formed with the container 10 prior to the sealing thereof or introduced to the container 10 after the container 10 has been sealed.


In some configurations, the accessor 20 is in fluid communication with the container 10, as indicated by an arrow 21. In certain of these configurations, when the pressure inside the container 10 varies from that of the surrounding environment, the introduction of the accessor 20 to the container 10 causes a transfer through the accessor 20. For example, in some arrangements, the pressure of the environment that surrounds the container 10 exceeds the pressure within the container 10, which may cause ambient air from the environment to ingress through the accessor 20 upon insertion of the accessor 20 into the container 10. In other arrangements, the pressure inside the container 10 exceeds that of the surrounding environment, causing the contents of the container 10 to egress through the accessor 20.


In some configurations, the accessor 20 is coupled with an exchange device 40. In certain instances, the accessor 20 and the exchange device 40 are separable. In some instances, the accessor 20 and the exchange device 40 are integrally formed. The exchange device 40 is configured to accept fluids and/or gases from the container 10 via the accessor 20, to introduce fluids and/or gases to the container 10 via the accessor 20, or to do some combination of the two. In some arrangements, the exchange device 40 is in fluid communication with the accessor 20, as indicated by an arrow 24. In certain configurations, the exchange device 40 comprises a medical instrument, such as a syringe.


In some instances, the exchange device 40 is configured to remove some or all of the contents of the container 10 via the accessor 20. In certain arrangements, the exchange device 40 can remove the contents independent of pressure differences, or lack thereof, between the interior of the container 10 and the surrounding environment. For example, in instances where the pressure outside of the container 10 exceeds that within the container 10, an exchange device 40 comprising a syringe can remove the contents of the container 10 if sufficient force is exerted to extract the plunger from the syringe. The exchange device 40 can similarly introduce fluids and/or gases to the container 10 independent of pressure differences between the interior of the container 10 and the surrounding environment.


In certain configurations, the regulator 30 is coupled with the container 10. The regulator 30 generally regulates the pressure within the container 10. As used herein, the term “regulate,” or any derivative thereof, is a broad term used in its ordinary sense and includes, unless otherwise noted, any active, affirmative, or positive activity, or any passive, reactive, respondent, accommodating, or compensating activity that tends to effect a change. In some instances, the regulator 30 substantially maintains a pressure difference, or equilibrium, between the interior of the container 10 and the surrounding environment. As used herein, the term “maintain,” or any derivative thereof, is a broad term used in its ordinary sense and includes the tendency to preserve an original condition for some period, with some small degree of variation permitted as may be appropriate in the circumstances. In some instances, the regulator 30 maintains a substantially constant pressure within the container 10. In certain instances, the pressure within the container 10 varies by no more than about 1 psi, no more than about 2 psi, no more than about 3 psi, no more than about 4 psi, or no more than about 5 psi. In still further instances, the regulator 30 equalizes pressures exerted on the contents of the container 10. As used herein, the term “equalize,” or any derivative thereof, is a broad term used in its ordinary sense and includes the tendency for causing quantities to be the same or close to the same, with some small degree of variation permitted as may be appropriate in the circumstances. In certain configurations, the regulator 30 is coupled with the container 10 to allow or encourage equalization of a pressure difference between the interior of the container 10 and some other environment, such as the environment surrounding the container 10 or an environment within the exchange device 40. In some arrangements, a single device comprises the regulator 30 and the accessor 20. In other arrangements, the regulator 30 and the accessor 20 are separate units.


The regulator 30 is generally in communication with the container 10, as indicated by an arrow 31, and a reservoir 50, as indicated by another arrow 35. In some configurations, the reservoir 50 comprises at least a portion of the environment surrounding the container 10. In some cases, the reservoir 50 is the ambient environment surrounding the container 10.


In certain embodiments, the regulator 30 provides fluid communication between the container 10 and the reservoir 50. In certain of such embodiments, the fluid in the reservoir 50 (e.g., in the surrounding environment) includes mainly gas so as not to appreciably dilute liquid contents of the container 10. In some arrangements, the regulator 30 comprises a filter to purify or remove contaminants from the gas or liquid entering the container 10, thereby reducing the risk of contaminating the contents of the container 10. In certain arrangements, the filter is hydrophobic such that air can enter the container 10 but fluid cannot escape therefrom. In some configurations, the regulator 30 comprises an orientation-actuated or orientation-sensitive check valve which selectively inhibits fluid communication between the container 10 and the filter. In some configurations, the regulator 30 comprises a check valve which selectively inhibits fluid communication between the container 10 and the filter when the valve and/or the container 10 are oriented so that the regulator 30 is held above (e.g., further from the floor than) the regulator 30.


As schematically illustrated in FIG. 2, in certain embodiments, the accessor 20, or some portion thereof, is located within the container 10. As detailed above, the accessor 20 can be integrally formed with the container 10 or separate therefrom. In some embodiments, the regulator 30, or some portion thereof, is located outside the container 10. In some arrangements, the regulator 30 is integrally formed with the container 10. It is possible to have any combination of the accessor 20, or some portion thereof, entirely within, partially within, or outside of the container 10 and/or the regulator 30, or some portion thereof, entirely within, partially within, or outside of the container 10.


In certain embodiments, the accessor 20 is in fluid communication with the container 10. In further embodiments, the accessor 20 is in fluid communication with the exchange device 40, as indicated by the arrow 24.


The regulator 30 can be in fluid or non-fluid communication with the container 10. In some embodiments, the regulator 30 is located entirely outside the container 10. In some embodiments, the regulator 30 is in communication, either fluid or non-fluid, with the reservoir 50, as indicated by the arrow 35.


As schematically illustrated in FIG. 2A, in certain embodiments, the accessor 20, or some portion thereof, can be located within the container 10. In some embodiments, the accessor 20, or some portion thereof, can be located outside the container 10. In some embodiments, a valve 25, or some portion thereof, can be located outside the container 10. In some embodiments, the valve 25, or some portion thereof, can be located within the container 10. In some embodiments, the regulator 30 is located entirely outside the container 10. In some embodiments, the regulator 30, or some portion thereof, can be located within the container 10. It is possible to have any combination of the accessor 20, or some portion thereof, entirely within, partially within, or outside of the container 10 and/or the valve 25, or some portion thereof, entirely within, partially within, or outside of the container 10. It is also possible to have any combination of the accessor 20, or some portion thereof, entirely within, partially within, or outside of the container 10 and/or the regulator 30, or some portion thereof, entirely within, partially within, or outside of the container 10.


The accessor 20 can be in fluid communication with the container 10, as indicated by the arrow 21. In some embodiments, the accessor 20 can be in fluid communication with the exchange device 40, as indicated by the arrow 24.


In certain embodiments, the regulator 30 can be in fluid or non-fluid communication with a valve 25, as indicated by the arrow 32. In some embodiments, the valve 25 can be integrally formed with the container 10 or separate therefrom. In some embodiments, the valve 25 can be integrally formed with the regulator 30 or separate therefrom. In certain embodiments, the valve 25 can be in fluid or non-fluid communication with the container 10, as indicated by the arrow 33.


In some embodiments the regulator 30 can be in fluid or non-fluid communication with the reservoir 50 (e.g., the ambient surroundings), as indicated by the arrow 35A.


According to some configurations, the regulator 30 can comprise a filter. In some embodiments, the filter can selectively inhibit passage of liquids and/or contaminants between the valve 25 and the reservoir 50. In some embodiments, the filter can selectively inhibit passage of liquids and/or contaminants between the reservoir 50 and the valve 25.


In some embodiments, the valve 25 can be a one-way check valve. In some embodiments, the valve 25 can be a two-way valve. According to some configurations, the valve 25 can selectively inhibit liquid communication between the filter and/or reservoir 50 and the container 10.


As illustrated in FIG. 2B, the regulator 30 can include a non-valved fluid connection 32A between the container 10, the regulator 30, and the reservoir 50. In some embodiments, the non-valved fluid connection is a second inlet/outlet between the regulator 30 and the reservoir 50. The second inlet/outlet can be filtered. For example, a hydrophobic and/or antimicrobial filter can be positioned in the regulator 30 between the second outlet and the container 10.


In certain embodiments, the adaptor 100 (e.g., a vial adaptor) comprises a piercing member 120, a cap connector 130, a connector interface 140, and a regulator assembly 150. Further details and examples regarding some embodiments of piercing members 120, cap connectors 130, and connector interfaces 140 are provided in U.S. Patent Application Publication No. 2009/0216212, the entirety of each of which is incorporated herein by reference and is made a part of this specification. For clarity, a vial is not illustrated. The adaptor 100 can mate with the vial in a similar manner as illustrated and described in U.S. patent application Ser. No. 14/179,475, filed Feb. 12, 2014, the entirety of which is incorporated herein by reference and is made a part of this specification. For example, when the adaptor 100 is mated with the vial, the piercing member 120 extends through a septum of the vial into the interior of the vial.


In some embodiments, such as in the illustrated embodiment, the cap connector 130 comprises a central portion 132 (that can be curved) and one or more tabs 134 (which can be opposing) attached to the central portion 132. Each of the tabs 134 can be supported at a proximal end of the tab 134 by the central portion 132 of the body portion 380. As shown, the distal end of the tabs 134 can each be unrestrained so as to allow the tab to deflect outward. As used herein the term, “proximal,” or any derivative thereof, refers to a direction along the axial length of the piercing member 120 that is toward the connector interface 140; the term “distal,” or any derivative thereof, indicates the opposite direction.


The cap connector 130, including the central portion 132 and tabs 134, can help removably secure the vial adaptor 100 to the outside surface of the vial and can help facilitate the removal of the vial adaptor 100 from the vial. In some embodiments, the cap connector 130 comprises only one tab 134, as opposed to a pair of opposing tabs 134, the single tab being configured to removably secure the vial adaptor 300 to the outside surface of the vial and to facilitate the removal of the vial adaptor 100 from the vial. The single tab 134 can be of any suitable configuration, including those set forth herein.


As illustrated in FIGS. 3-5, the connector interface 140 can have an interface centerline 142. The interface centerline 142 can extend substantially through a center of the connector interface 140 generally perpendicular to a proximal opening of the connector interface 140. In some embodiments, the interface centerline 142 extends through a substantial centerline of the piercing member 120. In some embodiments, the interface centerline 142 is perpendicular to the top of a vial to which the vial adaptor 100 is coupled.


As illustrated in FIG. 4, the regulator assembly 150 can include a regulator centerline 152. The regulator centerline 152 can extend substantially through the center of the regulator assembly 150. For example, in some embodiments, the regulator assembly 150 has a generally cylindrical shape, and the regulator centerline 152 extends through a central axis of the cylindrical regulator assembly 150. In some embodiments, the regulator assembly 150 does not have a straight configuration, and the centerline of the regulator assembly 150 is not a straight line. The regulator centerline 152 can be approximately perpendicular to the interface connector 140, as illustrated in FIG. 4. In some embodiments, the regulator centerline 152 extends at an oblique angle to the connector centerline 142. In some embodiments, the regulator centerline 152 intersects the connector centerline 142.


Referring to FIGS. 4 and 5, the regulator assembly 150 can include a first regulator inlet 154. The piercing member 120 can include a piercing tip 122. The piercing tip can be configured to pierce a septum or other seal of a vial to which the vial adaptor 100 is coupled. As illustrated in FIG. 4, the regulator assembly 150 can include a second regulator inlet 156. In some embodiments, a flow inhibitor, such as a valve or a hinged door (not shown), is connected to the second regulator inlet 156. The flow inhibitor can be configured to inhibit or prevent passage of fluids and/or solids into or out from the inlet 156 when the hinged door is in a closed position. In some embodiments, the flow inhibitor can be transitioned to an opened position by a user of the vial adaptor 100. One or more of the first regulator inlet 154 and the second regulator inlet 156 can be positioned along the regulator centerline 152. In some embodiments, both the first and second regulator inlets 154, 156 are positioned substantially collinear with each other. In some cases (not illustrated), the first regulator inlet 154 is positioned at an oblique, or non-collinear, or perpendicular angle with respect to the second regulator inlet 156. In some such cases, both the first and second regulator inlets 154, 156 are positioned on axes generally perpendicular to the interface centerline 142.


As illustrated in FIG. 7, the connector interface 140 can be in fluid communication with an access channel 142. The access channel 142 can extend into the vial when the vial adaptor 100 is coupled to the vial. In some embodiments, the access channel extends through the regulator assembly 150. The access channel 142 can have an access channel wall 144. The access channel wall 144 can inhibit or prevent fluid communication between the access channel 142 and the regulator assembly 150 (e.g., within the regulator assembly 150). The access channel 142 can extend from a proximal end at the connector interface 140 to a distal access aperture 146, at or near a distal end of the piercing member 120. The access channel 142 can provide fluid communication between a device (e.g., a syringe) coupled to the connector interface 140 and an interior of the vial or other container to which the vial adaptor 100 is coupled.


Referring to FIG. 7, the regulator assembly 150 can include a regulator housing 158. The regulator housing 158 can have a generally cylindrical shape, a generally rectangular shape, or some other shape. In some embodiments, the regulator housing 158 spans the access channel wall 142. In some cases, the regulator housing 158 is positioned only on one side of the access channel wall 142.


The regulator housing 158 can comprise a first regulator lumen 160. In some embodiments, the first regulator lumen 160 extends between the first regulator inlet 154 and the access channel wall 142. As illustrated, the first regulator lumen 160 can be in fluid communication with a regulator channel 162. The regulator channel 162 can extend at least partially through the piercing member 120. For example, the regulator channel 162 can extend between the first regulator lumen 160 and a distal regulator aperture 164. The distal regulator aperture 164 can be positioned at or near the piercing tip 122 of the piercing member 120. In some embodiments, the regulator channel 162 extends substantially parallel to the interface centerline 142.


In some embodiments, the regulator housing 158 comprises a second regulator lumen 182. The second regulator lumen 182 can extend between the second regulator inlet 156 and the access channel wall 142. In some cases, the second regulator lumen 182 is in fluid communication with one or more of the first regulator lumen 160 and the regulator channel 162. For example, as illustrated in FIG. 9, the first and second regulator lumens 160, 182 can be connected via a connecting channel 184. In some embodiments, the connecting channel 184 spans the access channel wall 142. As shown in FIG. 7, the first and second regulator lumens 160, 182 and/or the regulator valve 186 can be positioned along a common line that is generally perpendicular to the regulator channel 162.


As illustrated in FIG. 7, a regulator cap 166 can be positioned in or on the first regulator inlet 154. The regulator cap 166 can include a plug portion 168 configured to mate with or otherwise couple with the regulator housing 158. The plug portion 168 can be constructed from a flexible or semi-flexible material. In some embodiments, the plug portion 168 is constructed from a rigid or semi-rigid material. The plug portion 168 can be friction-fit with the regulator housing 158 (such as within the first regulator lumen 160, as illustrated in FIG. 7), adhered thereto, or otherwise fastened to the regulator housing 158. As shown in FIG. 7, the first filter can be positioned in the plug portion 168. The regulator cap 166 can include a cap portion 170. The cap portion 170 can be configured to limit the extent to which the plug portion 168 may be inserted into the regulator housing 158. For example, the cap portion 170 can have a cross-sectional width (e.g., a diameter) greater than the cross-sectional widths of the plug portion 168 and/or of the first regulator lumen 160.


In some embodiments, the plug portion 168 includes a hollow interior. The hollow interior of the plug portion 168 can comprise a first filter chamber 172. The first filter chamber 172 can be configured to receive a first filter 174. The first filter 174 can be adhered to or otherwise affixed to an interior of the plug portion 168 within the filter chamber 172. The filter 174 can inhibit or prevent passage of liquid and/or microbials past the filter 174. For example, the filter 174 can be hydrophobic and/or antimicrobial. In some embodiments, as shown in FIG. 7, the first filter 174 can be capable of fluid communication with the first regulator lumen 160. In some embodiments, the first filter 174 is positioned within the first regulator lumen 160 outside of the hollow interior of the plug portion 168 (e.g., outside of the first filter chamber 172).


As illustrated in FIG. 7, the second regulator inlet 156 can include a second filter chamber 176. The second filter chamber 176 can receive a second filter 178. The second filter 178 can be hydrophobic and/or antimicrobial. In some embodiments, the second filter chamber includes a filter seat 180. The filter seat 180 can be configured to inhibit or prevent accidental adherence of the filter 178 to one or more surfaces of the interior of the first regulator lumen 160. As illustrated, the second filter chamber 176 can be a portion of the second regulator lumen 182. In some embodiments, as shown in FIG. 7, the second filter 178 can be in fluid communication with the second regulator lumen 182.


As illustrated in FIGS. 7-10, the regulator assembly 150 can include a regulator valve 186. As shown in FIG. 7, the regulator valve 186 can be in fluid communication with the interior of the vial adaptor (e.g., with the first regulator lumen 160) and the regulator valve can be configured to permit passage of fluid from the ambient environment into the first regulator lumen. The regulator valve 186 can be configured to inhibit or prevent fluid flow into and/or out of the vial via the regulator channel 162. In some embodiments, as shown in FIG. 7, the regulator valve can be configured to prevent passage of fluid from within the vial to the first filter. In some embodiments, the regulator valve 186 is positioned in a fluid path between the first regulator inlet 154 and the distal regulator aperture 164. In some cases, the regulator valve 186 is positioned in a fluid path between the second regulator inlet 156 and the distal regulator aperture 164. In some embodiments, the regulator valve 186 is positioned at least partially within the regulator channel 162. In some cases, all or a portion of the regulator valve 186 is positioned within the first regulator lumen 160. The regulator valve 186 can be configured to transition between an opened configuration and a closed configuration. In some cases, the regulator valve 186 permits fluid flow in one or more directions between the distal regulator aperture 164 and the first and/or second regulator inlets 154, 156 when the regulator valve 186 is in the opened configuration. For example, the regulator valve 186 can be positioned and configured to operate as a one-way valve to permit fluid flow from the first regulator inlet 154 to the distal regulator aperture 164, but not from the distal regulator aperture 164 to the first regulator inlet 154, when the regulator valve 186 is in the opened configuration. In some embodiments, the regulator valve 186 inhibits or prevents fluid flow past the regulator valve 186 when the regulator valve 186 is in the closed configuration.


The regulator valve 186 can include a valve body 188. The valve body 188 can be configured to releasably mate with or fixedly mate with a valve seat 190. In some embodiments, at least a portion of the valve body 188 comprises an elastomeric, resilient, and/or flexible material. For example, the valve body 188 can be injection molded using an elastomeric material.


The valve body 188 can include a flap portion 191. The flap portion 191 can have a concave side 191a and a convex side 191b. In some embodiments, the flap portion 191 can have a generally circular shape, rectangular shape, oval shape, or other suitable shape. The flap portion 191 can extend outward from (e.g., radially outward with respect to the regulator centerline 152) a hub portion 189 of the valve body 186. In some embodiments, the flap portion includes a lip portion 193. The lip portion 193 can be positioned at or near a periphery of the flap portion 191.


In some embodiments, as shown, the flap portion 191 can be configured to produce a restoring force when the flap portion 191 is temporarily moved away from its natural concave or convex configurations (e.g., such as when the flap portion 191 is caused to become substantially flat, or less concave or less convex than in its natural position, or to essentially reverse its natural concave or convex sides) to bias the flap portion 191 back to its original shape and/or orientation. In some embodiments of this configuration, the flap portion 191 can temporarily permit the passage of fluid flow that exceeds a threshold pressure from the concave side of the flap portion 191 toward the convex side of the flap portion 191, but the flat portion 191 can resist, impede, or prevent the passage of fluid flow from the convex side of the flap portion 191 toward the concave side of the flap portion, even at extremely high pressure within the context of a vascular medical product.


In some embodiments, the valve seat 190 includes a valve stem 194. The valve stem 194 can have a first end 194a and a second end 194b. The valve stem 194 can extend from the flap portion 191 (e.g., from the concave side 191a of the flap portion 191). For example, the first end 194a can be connected to the hub portion 189 of the valve body 188 and the second end 194b of the valve body 188 can be spaced from the hub portion 189. The valve stem 194 can include a valve anchor 196. The valve anchor 196 can be, for example, one or more protrusions (e.g., an annular protrusion) or other features configured to inhibit accidental de-coupling between the valve body 188 and the valve seat 190. In some embodiments, the valve anchor 196 is positioned at or near the second end 194b of the valve stem 194.


In some cases, the valve seat 190 is formed as a portion of the regulator cap 166. As illustrated in FIGS. 7-10, the valve seat 190 can comprises a separate component configured to mate with or otherwise connect with the regulator cap 166. For example, the valve seat 190 can include a mating portion 198. The mating portion 198 can be configured to mate with the plug portion 168 of the regulator cap 166. In some embodiments, an outer cross-section of the mating portion 198 can be sized and shaped to substantially match an inner cross-section of the plug portion 168. In some embodiments, the mating portion 198 of the valve seat 190 is friction-fit to the plug portion 168. In some embodiments, adhesives or other mating materials are used to mate the mating portion 198 to the plug portion 168. The valve seat 190 can include a stop portion 200. The stop portion 200 can be configured to limit the extent to which the mating portion 198 is inserted into or over the plug portion 168. For example, the stop portion 200 can have a larger cross-sectional area than the mating portion 198.


The stop portion 200 or some other portion of the valve seat 190 or of the regulator cap 166 can include a seat aperture 202. The seat aperture 202 can have a cross-sectional shape configured to receive at least a portion of the valve stem 194. The stop portion 200 can have a thickness (e.g., as measured substantially parallel to the regulator centerline 152 in FIG. 7) such that the valve stem 194 and/or other portions of the valve body 188 are elastically deformed when the valve stem 194 is mated with the seat aperture 202. For example, the thickness of the stop portion 200 can be greater than a distance between the valve anchor 196 and the lip portion 193 of the valve body 188 when the valve body 188 is in a non-deformed configuration. In some embodiments, the lip portion 193 of the valve body 188 is deflected away from the valve anchor 196 when the valve stem 194 is mated with the seat aperture 202. Deflection of the lip portion 193 away from the valve anchor 196 can bias the lip portion 193 toward the stop portion 200. Contact between the lip portion 193 and the stop portion 200 of the valve seat 190 can form a seal to inhibit or prevent fluid flow through the valve seat 190 past the flap portion 191 of the valve body 188. In some embodiments, deflection of the lip portion 193 away from the valve anchor 196 can bias the regulator valve 186 to the closed configuration.


In some embodiments, the valve stem 194 includes a flexibility-increasing feature. For example, the valve stem 194 can include a cored portion 204. The cored portion 204 can increase the compressibility of the valve stem 194. In some embodiments, the cored portion 204 can increase a sealing force between the valve stem 194 and the seat aperture 202. For example, the cored portion 204 can facilitate insertion of a valve stem 194 having a larger width (e.g., diameter) than would otherwise be capable of insertion into the seat aperture 202.


As illustrated in FIG. 9, the valve seat 190 (e.g., the cap portion 200 of the valve seat 190) can include one or more valve channels 206. The valve channels 206 can facilitate fluid communication between the first regulator inlet 154 and the regulator valve 186. For example, the one or more valve channels 206 can facilitate fluid communication between the filter chamber 172 and the flap portion 191 of the regulator valve 186. In some embodiments, each of the one or more valve channels 206 is positioned within the periphery of the flap portion 191 of the regulator valve 186 (e.g., radially inside of the contact area between the lip portion 193 and the stop portion 200). In some embodiments, space between the valve stem 194 and the seat aperture can facilitate fluid communication between the filter chamber 172 and the flap portion 191 of the regulator valve 186.


The regulator assembly 150 can be configured to regulate pressure within the vial when compounds (e.g., liquids, gases, and/or solids) are introduced into or withdrawn from the vial. For example, introduction of a compound into the vial via the access channel 142 can increase the pressure within the vial. The regulator assembly 150 can be configured to release at least a portion of the excess pressure (e.g., the pressure above ambient pressure) by, for example, releasing gas from the vial through the second regulator inlet 156 via the regulator channel 162. As shown in FIG. 7, the second filter 178 can be configured to filter fluid passing from the second regulator lumen 182 into the ambient environment.


In some cases, the regulator assembly 150 can be configured to relieve pressure deficits within the vial. For example, withdrawing compounds from the vial via the access channel 142 can decrease the pressure within the vial. Decreased pressure within the vial can create a vacuum in the first regulator lumen 160 and/or in the second regulator lumen 176. The regulator assembly 150 can be configured to introduce ambient air (e.g., filtered ambient air) into the vial when a vacuum is created in the first and/or second regulator lumens 160, 176. For example, the regulator assembly 130 can draw ambient air into the vial via the second regulator inlet 156, through second filter 178, and/or through the regulator channel 162. In some cases (e.g., when the second regulator inlet 156 is partially or fully blocked or clogged), creation of a vacuum in the first regulator lumen 160 between the regulator valve 186 and the regulator channel 162 can create a pressure differential across the flap portion 191 of the regulator valve 186. For example, the pressure on the side of the flap portion 191 in communication with the first regulator inlet 154 can be approximately ambient pressure while the pressure on the side of the flap portion 191 in communication with the regulator channel 162 can be below ambient pressure. The regulator valve 186 can be configured to release the seal between the lip portion 193 of the flap portion 191 and the stop portion 200 of the valve seat 190 when the pressure differential across the flap portion 191 exceeds a threshold value (e.g., a cracking pressure). In some cases, the cracking pressure of the flap portion 191 can be greater than or equal to about 0.1 psi and/or less than or equal to about 5 psi. Release of the seal between the lip portion 193 of the flap portion 191 and the stop portion 200 of the valve seat 190 can transition the regulator valve 186 to an opened configuration. Transitioning the regulator valve 186 to the opened configuration can permit passage of air (e.g., filtered air) from the ambient surroundings into the vial. Introducing air from the ambient surroundings into the vial can increase the pressure within the vial and can reduce the pressure differential across the flap portion 191 of the regulator valve 186. Many variations are possible.


In some embodiments, the regulator valve 186 is configured to operate independent of the orientation of the valve adaptor 100. For example, the regulator valve 186 can be configured to operate in substantially the same manner whether the connector interface 140 is oriented above or below the piercing tip 122 of the piercing member 120. In some embodiments, the regulator valve 186 is configured to inhibit or prevent wetting of the first filter 174 from liquid within the vial. As explained above, the regulator valve 186 can operate as a one-way valve to permit fluid passage from the first regulator inlet 154 to the vial when the cracking pressure on the flap portion 191 of the regulator valve 186 is reached. Maintaining the first filter 174 in a dry condition can permit use of a small (e.g., small diameter) filter in the first filter chamber 172.



FIG. 11 illustrates an embodiment of a vial adaptor 1100 that can have any components or portions of any other vial adaptors disclosed herein. In some embodiments, the vial adaptor 1100 includes a connector interface 1140 and a piercing member 1120 in partial communication with the connector interface 1140. In some embodiments, the vial adaptor 1100 includes a regulator assembly 1150. As illustrated, the vial adaptor 1100 can be configured to regulate pressure within vial introduction of compounds to and/or withdrawal of compounds from the vial. Some numerical references to components in FIG. 11 are the same as or similar to those previously described for the vial adaptor 100 (e.g., piercing member 1120 v. piercing member 120). It is to be understood that the components can be the same in function or are similar in function to previously-described components. The adaptor 1100 of FIG. 11 shows certain variations to the adaptor 100 of FIGS. 1-10. As illustrated in FIG. 11, the regulator cap 1166 and valve seat 190 can form a unitary component. In some cases, the valve seat aperture 1200 can be positioned on the plug portion 1168 of the regulator cap 1166.


As illustrated in the figures of this application, including in FIG. 7, a pressure-regulating vial adaptor can be manufactured using any suitable manufacturing process that provides any or all of the components that are illustrated and/or described in this specification, either alone or in combination with one or more other components that are illustrated and/or described in this specification.


For expository purposes, the term “horizontal” as used herein is defined as a plane parallel to the plane or surface of the floor of the area in which the device being described is used or the method being described is performed, regardless of its orientation. The term “floor” floor can be interchanged with the term “ground.” The term “vertical” refers to a direction perpendicular to the horizontal as just defined. Terms such as “above,” “below,” “bottom,” “top,” “side,” “higher,” “lower,” “upper,” “over,” and “under,” are defined with respect to the horizontal plane.


The terms “approximately”, “about”, “generally” and “substantially” as used herein represent an amount close to the stated amount that still performs a desired function or achieves a desired result. For example, the terms “approximately”, “about”, “generally,” and “substantially” may refer to an amount that is within less than 10% of the stated amount.


Although the vial adaptor has been disclosed in the context of certain embodiments and examples, it will be understood by those skilled in the art that the vial adaptor extends beyond the specifically disclosed embodiments to other alternative embodiments and/or uses of the embodiments and certain modifications and equivalents thereof. For example, some embodiments do not include a second regulator inlet 156 and, instead, regulate pressure within the vial via the first regulator inlet 154. Accordingly, it is intended that the scope of the vial adaptor herein-disclosed should not be limited by the particular disclosed embodiments described above, but should be determined only by a fair reading of the claims that follow.

Claims
  • 1. An adaptor configured to couple with a sealed vial, the adaptor comprising: a connector interface;an access channel in fluid communication with the connector interface;a regulator assembly comprising: a first regulator inlet in fluid communication with an ambient environment surrounding the adaptor;a first regulator lumen;a second regulator inlet in fluid communication with the ambient environment;a second regulator lumen;a first filter capable of fluid communication with the first regulator lumen and configured to filter fluid passing into the first regulator lumen;a second filter in fluid communication with the second regulator lumen and configured to filter fluid passing from the second regulator lumen and into the ambient environment; anda regulator valve in fluid communication with the first regulator lumen, the regulator valve configured to permit passage of fluid from the ambient environment into the first regulator lumen, the regulator valve further configured to prevent passage of fluid from within the vial to the first filter, the regulator valve having a cracking pressure greater than or equal to 0.1 psi and less than or equal to 5 psi;a piercing member comprising a proximal end and a distal end, the distal end comprising a piercing tip; anda regulator channel positioned at least partially within the piercing member and comprising a first regulator channel opening in fluid communication with the first regulator lumen,wherein the regulator assembly is configured to permit passage of fluid from the second regulator lumen to exit the adaptor and into the ambient environment.
  • 2. The combination of the adaptor of claim 1 and the sealed vial.
  • 3. The adaptor of claim 1, wherein the regulator valve comprises a valve stem and a flap portion.
  • 4. The adaptor of claim 3, wherein the flap portion of the regulator valve comprises a concave side and a convex side.
  • 5. The adaptor of claim 4, wherein the flap portion is configured to inhibit passage of fluid from the convex side toward the concave side.
  • 6. The adaptor of claim 1 further comprising a valve seat being configured to releasably couple with the regulator valve.
  • 7. The adaptor of claim 6, wherein the regulator valve comprises a valve anchor configured to inhibit decoupling of the regulator valve and the valve seat.
  • 8. The adaptor of claim 7, wherein the valve anchor comprises one or more protrusions.
  • 9. The adaptor of claim 6, wherein the valve seat comprises: a mating portion configured to engage with a plug portion that is inserted into the first regulator lumen; anda stop portion configured to limit the extent to which the mating portion engages the plug portion.
  • 10. The adaptor of claim 9, wherein the mating portion engages with the plug portion via a friction fit.
  • 11. The adaptor of claim 9, wherein the stop portion comprises a cross-sectional area that is larger than a cross-sectional area of the mating portion.
  • 12. The adaptor of claim 6, wherein the valve seat comprises one or more valve channels configured to facilitate fluid communication between the first regulator inlet and the regulator valve.
  • 13. The adaptor of claim 1, wherein the regulator valve is positioned in a plug portion that is inserted into the first regulator lumen.
  • 14. The adaptor of claim 13, wherein the plug portion is retained within the first regulator lumen by a friction fit.
  • 15. The adaptor of claim 13, wherein a cap portion limits the extent to which the plug portion is inserted into the regulator lumen.
  • 16. The adaptor of claim 15, wherein the first filter is positioned in the plug portion.
  • 17. A method of manufacturing a vial adaptor comprising the steps of: providing a connector interface;providing an access channel in fluid communication with the connector interface;providing a regulator assembly comprising: a first regulator inlet in fluid communication with an ambient environment surrounding the adaptor;a second regulator inlet in fluid communication with the ambient environment;a first filter configured to filter fluid passing into the vial adaptor;a second filter configured to filter fluid passing from the vial adaptor into the ambient environment; anda regulator valve configured to permit passage of fluid from the ambient environment into the vial adaptor, the regulator valve further configured to inhibit passage of fluid from within the vial to the first filter, the regulator valve having a cracking pressure greater than or equal to 0.1 psi and less than or equal to 5 psi,wherein the regulator assembly is configured to permit passage of fluid from the vial adaptor to exit the adaptor and into the ambient environment;providing a piercing member comprising a proximal end and a distal end, the distal end comprising a piercing tip; andproviding a regulator channel positioned at least partially within the piercing member and comprising a first regulator channel opening, the regulator channel being in fluid communication with the second filter and the regulator valve.
  • 18. The method of claim 17, wherein the regulator valve comprises a valve stem and a flap portion, wherein the flap portion comprises a concave side and a convex side, and wherein the flap portion is configured to inhibit passage of fluid from the convex side toward the concave side.
  • 19. The method of claim 17, wherein the regulator assembly further comprises a valve seat being configured to releasably couple with the regulator valve, and wherein the regulator valve comprises a valve anchor configured to inhibit decoupling of the regulator valve and the valve seat.
  • 20. The method of claim 17, wherein the valve seat comprises one or more valve channels configured to facilitate fluid communication between the first regulator inlet and the regulator valve.
RELATED APPLICATIONS

This application is a continuation of U.S. patent application Ser. No. 15/384,078, filed Dec. 19, 2016, entitled “PRESSURE-REGULATING VIAL ADAPTORS,” which claims the benefit of International Application No. PCT/US2015/036305, filed on Jun. 17, 2015, entitled “PRESSURE-REGULATING VIAL ADAPTORS,” which claims the benefit of priority to U.S. Provisional Patent Application No. 62/014,872, filed on Jun. 20, 2014, entitled “PRESSURE-REGULATING VIAL ADAPTORS,” the entire contents of which are incorporated by reference herein and made part of this specification.

US Referenced Citations (439)
Number Name Date Kind
2074223 Horiuchi et al. Mar 1937 A
2409734 Bucher et al. Oct 1946 A
2419401 Hinds Apr 1947 A
2668533 Evans Feb 1954 A
2673013 Hester Mar 1954 A
2852024 Ryan Jul 1954 A
2793758 Murrish Mar 1961 A
2999499 Willet Sep 1961 A
2999500 Schurer Sep 1961 A
3291151 Loken Dec 1966 A
RE26488 Bull Nov 1968 E
3542240 Solowey Nov 1970 A
3557778 Hughes Jan 1971 A
3584770 Taylor Jun 1971 A
3797521 King Mar 1974 A
3822700 Pennington Jul 1974 A
3844283 Dabney Oct 1974 A
3853157 Madaio Dec 1974 A
3923058 Weingarten Dec 1975 A
3938520 Scislowcz et al. Feb 1976 A
3940003 Larson Feb 1976 A
3941167 Haury-Wirtz et al. Mar 1976 A
3957082 Fuson et al. May 1976 A
3980082 Miller Sep 1976 A
3993063 Larrabee Nov 1976 A
4046291 Goda Sep 1977 A
4058121 Choski et al. Nov 1977 A
4143853 Abramson Mar 1979 A
4207923 Giurtino Jun 1980 A
4219021 Fink Aug 1980 A
4240433 Bordow Dec 1980 A
4240833 Myles Dec 1980 A
4253459 Willis Mar 1981 A
4262671 Kersten Apr 1981 A
4301799 Pope, Jr. et al. Nov 1981 A
4312349 Cohen Jan 1982 A
4314586 Folkman Feb 1982 A
4334551 Pfister Jun 1982 A
4349035 Thomas et al. Sep 1982 A
4376634 Prior et al. Mar 1983 A
4381776 Latham, Jr. May 1983 A
4396016 Becker Aug 1983 A
4410321 Pearson et al. Oct 1983 A
4458733 Lyons Jul 1984 A
4475915 Sloane Oct 1984 A
4493348 Lemmons Jan 1985 A
4505709 Froning et al. Mar 1985 A
4534758 Akers et al. Aug 1985 A
4564054 Gustaysson Jan 1986 A
4573993 Hoag et al. Mar 1986 A
4576211 Valentini et al. Mar 1986 A
4588403 Weiss et al. May 1986 A
4600040 Naslund Jul 1986 A
4645073 Homan Feb 1987 A
4673404 Gustavsson Jun 1987 A
4730635 Linden Mar 1988 A
4735608 Sardam Apr 1988 A
4743243 Vaillancourt May 1988 A
4768568 Fournier et al. Sep 1988 A
4785859 Gustavsson et al. Nov 1988 A
4798578 Ranford Jan 1989 A
4857068 Kahn Aug 1989 A
4929230 Pfleger May 1990 A
4981464 Suzuki Jan 1991 A
5006114 Rogers Apr 1991 A
5060704 Rohrbough Oct 1991 A
5169393 Moorehead et al. Dec 1992 A
5176673 Marrucchi Jan 1993 A
5334163 Sinnett Aug 1994 A
5349984 Weinheimer et al. Sep 1994 A
5405331 Behnke et al. Apr 1995 A
5445630 Richmond Aug 1995 A
5478337 Okamoto et al. Dec 1995 A
5580351 Helgren et al. Dec 1996 A
5660796 Sheehy Aug 1997 A
5685866 Lopez Nov 1997 A
5700245 Sancoff et al. Dec 1997 A
5725500 Micheler Mar 1998 A
5749394 Boehmer et al. May 1998 A
5766147 Sancoff et al. Jun 1998 A
5772079 Gueret Jun 1998 A
5776125 Dudar et al. Jul 1998 A
5803311 Fuchs Sep 1998 A
5833213 Ryan Nov 1998 A
5890610 Jansen et al. Apr 1999 A
6003553 Wahlberg Dec 1999 A
6071270 Fowles et al. Jun 2000 A
6139534 Niedospial et al. Oct 2000 A
6159192 Fowles et al. Dec 2000 A
6358236 DeFoggi et al. Mar 2002 B1
6457488 Loo Oct 2002 B2
6478788 Aneas Nov 2002 B1
6544246 Niedospial, Jr. Apr 2003 B1
6551299 Miyoshi et al. Apr 2003 B2
6572256 Seaton et al. Jun 2003 B2
6679290 Matthews et al. Jan 2004 B2
6692478 Paradis Feb 2004 B1
6715520 Andreasson et al. Apr 2004 B2
6719719 Carmel et al. Apr 2004 B2
6832994 Niedospial, Jr. et al. Dec 2004 B2
6890328 Fowles et al. May 2005 B2
6989002 Guala Jan 2006 B2
6997910 Howlett et al. Feb 2006 B2
6997917 Niedospial, Jr. et al. Feb 2006 B2
7004926 Navia et al. Feb 2006 B2
7048720 Thorne, Jr. et al. May 2006 B1
7086431 D'Antonio et al. Aug 2006 B2
7101354 Thorne, Jr. et al. Sep 2006 B2
7140401 Wilcox et al. Nov 2006 B2
7192423 Wong Mar 2007 B2
7213702 Takimoto et al. May 2007 B2
7291131 Call Nov 2007 B2
7306584 Wessman et al. Dec 2007 B2
7326194 Zinger et al. Feb 2008 B2
7354427 Fangrow Apr 2008 B2
7507227 Fangrow Mar 2009 B2
7510547 Fangrow Mar 2009 B2
7510548 Fangrow Mar 2009 B2
7513895 Fangrow Apr 2009 B2
7530546 Ryan May 2009 B2
7534238 Fangrow May 2009 B2
7547300 Fangrow Jun 2009 B2
7569043 Fangrow Aug 2009 B2
7618408 Yandell Nov 2009 B2
7632261 Zinger et al. Dec 2009 B2
7645271 Fangrow Jan 2010 B2
7654995 Warren et al. Feb 2010 B2
7658733 Fangrow Feb 2010 B2
7678333 Reynolds et al. Mar 2010 B2
7703486 Costanzo Apr 2010 B2
7731678 Tennican et al. Jun 2010 B2
7743799 Mosler et al. Jun 2010 B2
7744580 Reboul Jun 2010 B2
7758560 Connell et al. Jul 2010 B2
7789871 Yandell Sep 2010 B1
7799009 Niedospial, Jr. et al. Sep 2010 B2
D630732 Lev et al. Jan 2011 S
7862537 Zinger et al. Jan 2011 B2
7879018 Zinger et al. Feb 2011 B2
7883499 Fangrow Feb 2011 B2
7887528 Yandell Feb 2011 B2
7900659 Whitley et al. Mar 2011 B2
D637713 Nord et al. May 2011 S
7942860 Horppu May 2011 B2
7963954 Kavazov Jun 2011 B2
D641080 Zinger et al. Jul 2011 S
7972321 Fangrow Jul 2011 B2
7975733 Horppu et al. Jul 2011 B2
7981089 Weilbacher Jul 2011 B2
7981101 Walsh Jul 2011 B2
7998106 Thorne, Jr. et al. Aug 2011 B2
8021325 Zinger et al. Sep 2011 B2
8025653 Capitqaine et al. Sep 2011 B2
8029747 Helmerson Oct 2011 B2
8074964 Mansour et al. Dec 2011 B2
8096525 Ryan Jan 2012 B2
8100154 Reynolds et al. Jan 2012 B2
8109285 Ehrman et al. Feb 2012 B2
8123736 Kraushaar et al. Feb 2012 B2
8141601 Fehr et al. Mar 2012 B2
8156971 Costanzo Apr 2012 B2
8162006 Guala Apr 2012 B2
8162013 Rosenquist et al. Apr 2012 B2
8162914 Kraushaar et al. Apr 2012 B2
8167863 Yow May 2012 B2
8167864 Browne May 2012 B2
8172794 Lum et al. May 2012 B2
8177768 Leinsing May 2012 B2
8196614 Kriheli Jun 2012 B2
8197459 Jansen et al. Jun 2012 B2
8206367 Warren et al. Jun 2012 B2
8211082 Hasegawa et al. Jul 2012 B2
8221382 Moy et al. Jul 2012 B2
8225826 Horppu et al. Jul 2012 B2
8231567 Tennican et al. Jul 2012 B2
8241265 Moy et al. Aug 2012 B2
8262643 Tennican Sep 2012 B2
8267127 Kriheli Sep 2012 B2
8267913 Fangrow Sep 2012 B2
8281807 Trombley, III et al. Oct 2012 B2
8286936 Kitani et al. Oct 2012 B2
8287513 Ellstrom et al. Oct 2012 B2
8336587 Rosenquist et al. Dec 2012 B2
8356644 Chong et al. Jan 2013 B2
8356645 Chong et al. Jan 2013 B2
8357137 Yandell Jan 2013 B2
8366658 Davis et al. Feb 2013 B2
8381776 Horppu Feb 2013 B2
8403905 Yow Mar 2013 B2
8409164 Fangrow Apr 2013 B2
8409165 Niedospial et al. Apr 2013 B2
8425487 Beiriger et al. Apr 2013 B2
8449521 Thorne, Jr. et al. May 2013 B2
8454579 Fangrow, Jr. Jun 2013 B2
8469939 Fangrow Jun 2013 B2
8506548 Okiyama Aug 2013 B2
8511352 Kraus et al. Aug 2013 B2
8512307 Fangrow Aug 2013 B2
8522832 Lopez et al. Sep 2013 B2
8523838 Tornqvist Sep 2013 B2
8540692 Fangrow Sep 2013 B2
8602067 Kuhni et al. Dec 2013 B2
8608723 Lev et al. Dec 2013 B2
8622985 Ellstrom Jan 2014 B2
8657803 Helmerson et al. Feb 2014 B2
8667996 Gonnelli et al. Mar 2014 B2
8684992 Sullivan et al. Apr 2014 B2
8684994 Lev et al. Apr 2014 B2
8701696 Guala Apr 2014 B2
8702675 Imai Apr 2014 B2
8720496 Huwiler et al. May 2014 B2
8721614 Takemoto et al. May 2014 B2
8753325 Lev et al. Jun 2014 B2
8795231 Chong et al. Aug 2014 B2
8801678 Panian et al. Aug 2014 B2
8821436 Mosler et al. Sep 2014 B2
8827977 Fangrow Sep 2014 B2
8864725 Ranalletta et al. Oct 2014 B2
8864737 Hasegawa et al. Oct 2014 B2
8870832 Raday et al. Oct 2014 B2
8870846 Davis et al. Oct 2014 B2
8882738 Fangrow et al. Nov 2014 B2
8900212 Kubo Dec 2014 B2
8910919 Bonnal et al. Dec 2014 B2
8926554 Okuda et al. Jan 2015 B2
8945084 Warren et al. Feb 2015 B2
8973622 Lopez Mar 2015 B2
8974433 Fangrow Mar 2015 B2
8979792 Lev et al. Mar 2015 B2
8986262 Young et al. Mar 2015 B2
8992501 Seifert et al. Mar 2015 B2
9005179 Fangrow et al. Apr 2015 B2
9005180 Seifert et al. Apr 2015 B2
9060921 Seifert et al. Jun 2015 B2
9067049 Panian et al. Jun 2015 B2
9072657 Seifert et al. Jul 2015 B2
9089474 Cederschiöld Jul 2015 B2
9089475 Fangrow Jul 2015 B2
9107808 Fangrow Aug 2015 B2
9132062 Fangrow Sep 2015 B2
9132063 Lev et al. Sep 2015 B2
9144646 Barron, III et al. Sep 2015 B2
9198832 Moy et al. Dec 2015 B2
9205248 Wu et al. Dec 2015 B2
9211231 Mansour et al. Dec 2015 B2
9278206 Fangrow Mar 2016 B2
9345640 Mosier et al. May 2016 B2
9345641 Kraus et al. May 2016 B2
9351905 Fangrow et al. May 2016 B2
9358182 Garfield et al. Jun 2016 B2
9381135 Reynolds et al. Jul 2016 B2
9381137 Garfield et al. Jul 2016 B2
9381339 Wu et al. Jul 2016 B2
9440060 Fangrow Sep 2016 B2
9511989 Lopez Dec 2016 B2
9572750 Mansour et al. Feb 2017 B2
9585812 Browka et al. Mar 2017 B2
9597260 Ivosevic Mar 2017 B2
9610217 Fangrow Apr 2017 B2
9615997 Fangrow Apr 2017 B2
9662272 Warren et al. May 2017 B2
9763855 Fangrow et al. Sep 2017 B2
9827163 Lopez et al. Nov 2017 B2
9895291 Fangrow Feb 2018 B2
9931275 Fangrow Apr 2018 B2
9931276 Lopez Apr 2018 B2
9987195 Fangrow Jun 2018 B2
9993390 Seifert et al. Jun 2018 B2
9993391 Warren et al. Jun 2018 B2
9999569 Kriheli Jun 2018 B2
10016339 Guala Jul 2018 B2
10022302 Warran et al. Jul 2018 B2
10071020 Warren et al. Sep 2018 B2
10086188 Fangrow Oct 2018 B2
10117807 Fangrow Nov 2018 B2
10201476 Fangrow Feb 2019 B2
10327989 Fangrow Jun 2019 B2
10327991 Seifert et al. Jun 2019 B2
10327992 Fangrow et al. Jun 2019 B2
10327993 Fangrow et al. Jun 2019 B2
10369349 Nelson Aug 2019 B2
10391293 Fangrow Aug 2019 B2
10406072 Chhikara et al. Sep 2019 B2
10688022 Fangrow Jun 2020 B2
10806672 Fangrow Oct 2020 B2
20020087144 Zinger et al. Jul 2002 A1
20020095133 Gillis et al. Jul 2002 A1
20020193777 Aneas Dec 2002 A1
20030153895 Leinsing Aug 2003 A1
20030216695 Yang Nov 2003 A1
20030229330 Hickle Dec 2003 A1
20040073169 Amisar et al. Apr 2004 A1
20040073189 Wyatt et al. Apr 2004 A1
20050087715 Doyle Apr 2005 A1
20050131357 Denton et al. Jun 2005 A1
20050148992 Simas, Jr. et al. Jul 2005 A1
20050203481 Orlu et al. Sep 2005 A1
20060025747 Sullivan et al. Feb 2006 A1
20060111667 Matsuura et al. May 2006 A1
20060149309 Paul et al. Jul 2006 A1
20060184103 Paproski et al. Aug 2006 A1
20060184139 Quigley et al. Aug 2006 A1
20070093775 Daly Apr 2007 A1
20070106244 Mosler May 2007 A1
20070208320 Muramatsu et al. Sep 2007 A1
20080045919 Jakob et al. Feb 2008 A1
20080067462 Miller et al. Mar 2008 A1
20080142388 Whitley et al. Jun 2008 A1
20080172003 Plishka et al. Jul 2008 A1
20080208159 Stanus et al. Aug 2008 A1
20090057258 Tornqvist Mar 2009 A1
20090200504 Ryan Aug 2009 A1
20100059474 Brandenburger et al. Mar 2010 A1
20100106129 Goeckner et al. Apr 2010 A1
20100160889 Smith et al. Jun 2010 A1
20100179506 Shemesh et al. Jul 2010 A1
20100249723 Fangrow, Jr. Sep 2010 A1
20100305548 Kraushaar Dec 2010 A1
20110004183 Carrez et al. Jan 2011 A1
20110062703 Lopez et al. Mar 2011 A1
20110108158 Huwiler et al. May 2011 A1
20110125104 Lynn May 2011 A1
20110125128 Nord et al. May 2011 A1
20110175347 Okiyama Jul 2011 A1
20110184382 Cady Jul 2011 A1
20110224611 Lum et al. Sep 2011 A1
20110240158 Py Oct 2011 A1
20110257621 Fangrow Oct 2011 A1
20110264037 Foshee et al. Oct 2011 A1
20120046636 Kriheli Feb 2012 A1
20120059346 Sheppard et al. Mar 2012 A1
20120067429 Mosler et al. Mar 2012 A1
20120078091 Suchecki Mar 2012 A1
20120078214 Finke et al. Mar 2012 A1
20120078215 Finke et al. Mar 2012 A1
20120109077 Ryan May 2012 A1
20120157964 Haimi Jun 2012 A1
20120215181 Lee Aug 2012 A1
20120298254 Brem et al. Nov 2012 A1
20120302986 Brem et al. Nov 2012 A1
20130030386 Panian et al. Jan 2013 A1
20130033034 Trombley, III et al. Feb 2013 A1
20130035668 Kitani et al. Feb 2013 A1
20130053814 Mucientes et al. Feb 2013 A1
20130053815 Mucientes et al. Feb 2013 A1
20130060226 Fini et al. Mar 2013 A1
20130102974 Davis et al. Apr 2013 A1
20130110053 Yoshino et al. May 2013 A1
20130130197 Jessop et al. May 2013 A1
20130180618 Py Jul 2013 A1
20130190684 Panian et al. Jul 2013 A1
20130218121 Waller et al. Aug 2013 A1
20130226099 Fangrow Aug 2013 A1
20130228239 Cederschiöld Sep 2013 A1
20130306169 Weibel Nov 2013 A1
20140020792 Kraus et al. Jan 2014 A1
20140107588 Fangrow Apr 2014 A1
20140124087 Anderson et al. May 2014 A1
20140124092 Gonnelli et al. May 2014 A1
20140150925 Sjogren et al. Jun 2014 A1
20140261860 Heath et al. Sep 2014 A1
20140261877 Ivosevic et al. Sep 2014 A1
20140276649 Ivosevic et al. Sep 2014 A1
20140358073 Panian et al. Dec 2014 A1
20150011963 Fangrow Jan 2015 A1
20150020920 Lev et al. Jan 2015 A1
20150065987 Fangrow et al. Mar 2015 A1
20150082746 Ivosevic et al. Mar 2015 A1
20150123398 Sanders et al. May 2015 A1
20150126958 Sanders et al. May 2015 A1
20150157848 Wu et al. Jun 2015 A1
20150202121 Seifert et al. Jul 2015 A1
20150209230 Lev et al. Jul 2015 A1
20150209233 Fukuoka Jul 2015 A1
20150250680 Browka et al. Sep 2015 A1
20150250681 Lev et al. Sep 2015 A1
20150265500 Russo et al. Sep 2015 A1
20150297451 Marici et al. Oct 2015 A1
20150297453 Kim et al. Oct 2015 A1
20150297454 Sanders et al. Oct 2015 A1
20150297456 Marici et al. Oct 2015 A1
20150297459 Sanders et al. Oct 2015 A1
20150297461 Fangrow Oct 2015 A1
20150297817 Guala Oct 2015 A1
20150297839 Sanders et al. Oct 2015 A1
20150320642 Fangrow Nov 2015 A1
20150320992 Bonnet et al. Nov 2015 A1
20150359709 Kriheli et al. Dec 2015 A1
20150366758 Noguchi et al. Dec 2015 A1
20160000653 Kramer Jan 2016 A1
20160008534 Cowan et al. Jan 2016 A1
20160038373 Ohlin Feb 2016 A1
20160038374 Merhold et al. Feb 2016 A1
20160051446 Lev et al. Feb 2016 A1
20160058667 Kriheli Mar 2016 A1
20160081878 Marks et al. Mar 2016 A1
20160081879 Garfield et al. Mar 2016 A1
20160101020 Guala Apr 2016 A1
20160106970 Fangrow Apr 2016 A1
20160120753 Warren May 2016 A1
20160120754 Warren May 2016 A1
20160136051 Lavi May 2016 A1
20160136412 McKinnon et al. May 2016 A1
20160206511 Garfield et al. Jul 2016 A1
20160206512 Chhikara et al. Jul 2016 A1
20160213568 Mansour et al. Jul 2016 A1
20160250102 Garfield et al. Sep 2016 A1
20160262981 Carrez et al. Sep 2016 A1
20160262982 Cederschiold Sep 2016 A1
20160338911 Fangrow Nov 2016 A1
20170095404 Fangrow Apr 2017 A1
20170196772 Seifert Jul 2017 A1
20170196773 Fangrow Jul 2017 A1
20170202744 Fangrow Jul 2017 A1
20170202745 Seifert Jul 2017 A1
20170239140 Fangrow Aug 2017 A1
20170258682 Kriheli Sep 2017 A1
20170296431 Fangrow Oct 2017 A1
20170312176 Fangrow Nov 2017 A1
20170333288 Fangrow Nov 2017 A1
20180028402 Kriheli et al. Feb 2018 A1
20180099137 Fangrow Apr 2018 A1
20180125759 Fangrow May 2018 A1
20180161245 Kriheli Jun 2018 A1
20180193227 Marci et al. Jul 2018 A1
20180207063 Lopez et al. Jul 2018 A1
20180221572 Schlitt et al. Aug 2018 A1
20180250195 Fangrow Sep 2018 A1
20180280240 Fangrow Oct 2018 A1
20190000717 Fangrow Jan 2019 A1
20190001114 Fangrow Jan 2019 A1
20190254926 Seifert Aug 2019 A1
20190269900 Fangrow Sep 2019 A1
20190350812 Chhikara Nov 2019 A1
20190358125 Chhikara Nov 2019 A1
20200069519 Fangrow Mar 2020 A1
20200069520 Fangrow Mar 2020 A1
20200093695 Seifert Mar 2020 A1
20200337948 Fangrow Oct 2020 A1
Foreign Referenced Citations (28)
Number Date Country
2013200393 Feb 2013 AU
1037428 Aug 1978 CA
0 829 250 Mar 1998 EP
2 000 685 Jan 1979 GB
39-17386 Aug 1961 JP
45-20604 Aug 1970 JP
57-208362 Dec 1982 JP
H02-193677 Jul 1990 JP
H06-66682 Sep 1994 JP
2015-077217 Apr 2015 JP
WO 1984004673 Dec 1984 WO
WO 199702853 Jan 1997 WO
WO 2000035517 Jun 2000 WO
WO 2005065626 Jul 2005 WO
WO 2008036101 Mar 2008 WO
WO 2008153459 Dec 2008 WO
WO 2008153460 Dec 2008 WO
WO 2009097146 Aug 2009 WO
WO 2010069359 Jun 2010 WO
WO 2010093581 Aug 2010 WO
WO 2010120953 Oct 2010 WO
WO 2013104736 Jul 2013 WO
WO 2013134246 Sep 2013 WO
WO 2014116602 Jul 2014 WO
WO 2015029018 Mar 2015 WO
WO 2016147178 Sep 2016 WO
WO 2018064206 Apr 2018 WO
WO 2018186361 Oct 2018 WO
Non-Patent Literature Citations (10)
Entry
Clave—NeedleFree Connector, 2-page brochure. Jan. 2012 ICU Medical, Inc. (M1-1065 Rev. 04).
Equashield, Hazardous Drugs Closed System Transfer Device. Two webpages: http:/www.equashield.com, downloaded Jul. 22, 2013.
Genie—Closed Vial Access Device, 2-page brochure. Jan. 2012 ICU Medical, Inc. (M1-1186 Rev. 11).
International Search Report and Written Opinon dated Aug. 31, 2015, re PCT Application No. PCT/US2015-036305.
International Preliminary Report on Patentability dated Dec. 20, 2016, re PCT Application No. PCT/US2015/036305.
OnGuard Contained Medication System with Tevadaptor Components, B. Braun Medical, Inc., Apr. 2007.
Phaseal, The PhaSeal® Solution, http://www.phaseal.com/siteUS/page.asp?menuitem=145&right=0, dated Jan. 9, 2006.
Phaseal, How to Use PhaSeal®, http://www.phaseal.com/siteUS/movies.asp?main=filmsmain&right=filmsright, dated Jul. 25, 2005.
“Protection Safety Products”, IV Sets and Access Devices Medication Delivery Catalog, Chemo-Aide Dispensing Pin, Dec. 2002, pp. 7,21, Baxter Healthcare Corporation, Round Lake, IL.
Spiros—Closed Male Luer. 2-page brochure. Jan. 2012 ICU Medical, Inc. (M1-1184 Rev. 11).
Related Publications (1)
Number Date Country
20190117515 A1 Apr 2019 US
Provisional Applications (1)
Number Date Country
62014872 Jun 2014 US
Continuations (2)
Number Date Country
Parent 15384078 Dec 2016 US
Child 16223499 US
Parent PCT/US2015/036305 Jun 2015 US
Child 15384078 US